Immix Biopharma (IMMX) Stock Chart & Stock Price History $1.84 +0.02 (+1.10%) (As of 09:44 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immix Biopharma Stock Price Performance 5 Day Performance+15.72%1 Month Performance+15.00%3 Month Performance-19.30%6 Month Performance-20.00%Year-To-Date Performance-73.41%1 Year Performance-56.09% Receive IMMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] IMMX Stock Chart for Thursday, November, 21, 2024 IMMX Chart by TradingView Immix Biopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$1.70$1.82+7.06%$1.93$1.65439,412 shs$50.07 million11/19/2024$1.69$1.70+0.59%$1.78$1.6591,688 shs$46.77 million11/18/2024$1.59$1.69+6.29%$1.80$1.58113,343 shs$46.49 million11/15/2024$1.62$1.59-1.85%$1.64$1.5457,107 shs$43.74 million11/14/2024$1.57$1.62+3.18%$1.66$1.5736,367 shs$44.47 million11/13/2024$1.72$1.57-8.72%$1.74$1.5557,786 shs$43.10 million Get the Latest News and Ratings for IMMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$1.77$1.72-2.82%$1.78$1.6939,264 shs$47.21 million11/11/2024$1.86$1.77-4.84%$1.91$1.7570,365 shs$48.59 million11/08/2024$1.75$1.86+6.29%$1.95$1.70167,627 shs$51.06 million11/07/2024$1.60$1.75+9.37%$1.78$1.5390,916 shs$48.04 million11/06/2024$1.60$1.60$1.65$1.5791,587 shs$43.92 million11/05/2024$1.58$1.60+1.27%$1.60$1.4865,563 shs$43.92 million11/04/2024$1.59$1.58-0.63%$1.62$1.5428,393 shs$43.37 million11/01/2024$1.60$1.59-0.63%$1.66$1.5529,518 shs$43.65 million10/31/2024$1.65$1.60-3.03%$1.66$1.5748,986 shs$43.92 million10/30/2024$1.71$1.65-3.51%$1.71$1.6246,496 shs$43.58 million10/29/2024$1.68$1.71+1.79%$1.76$1.6373,316 shs$45.17 million10/28/2024$1.66$1.68+1.20%$1.77$1.6252,726 shs$44.38 million10/25/2024$1.59$1.66+4.40%$1.67$1.56128,218 shs$43.85 million10/24/2024$1.63$1.59-2.45%$1.65$1.5840,575 shs$42.00 million10/23/2024$1.65$1.63-1.21%$1.66$1.5754,336 shs$43.06 million10/22/2024$1.60$1.65+3.12%$1.67$1.5366,305 shs$43.58 million10/21/2024$1.72$1.60-6.98%$1.75$1.5983,418 shs$42.26 million Related Companies RAPT Therapeutics Stock Chart BioAtla Stock Chart Acrivon Therapeutics Stock Chart Lexeo Therapeutics Stock Chart Corbus Pharmaceuticals Stock Chart XBiotech Stock Chart Solid Biosciences Stock Chart Editas Medicine Stock Chart ADC Therapeutics Stock Chart Opthea Stock Chart Receive IMMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMMX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
